Skip to main content
Clinical Trials/NCT00064649
NCT00064649TerminatedPhase 3

Minimally Invasive Surgical Therapy Consortium for Benign Prostatic Hyperplasia

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)7 sites in 1 country49 target enrollmentStarted: April 2004Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Phase 3
Status
Terminated
Enrollment
49
Locations
7

Study Overview

Brief Summary

The primary objective of this randomized clinical trial is to determine the efficacy and safety of three treatments for benign prostatic hyperplasia (BPH): transurethral needle ablation (TUNA), transurethral microwave therapy (TUMT), and medical therapy with alfuzosin and finasteride.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
50 Years to — (Adult, Older Adult)
Sex
Male
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Arms & Interventions

2

Active Comparator

Transurethral Needle Ablation (TUNA)

Intervention: Transurethral Needle Ablation (TUNA) Therapy (Device)

3

Active Comparator

finasteride in a daily dose of 5 mg and alfuzosin in a daily dose of 10 mg

Intervention: Finasteride and Alfuzosin (Drug)

1

Active Comparator

Transurethral Microwave Thermotherapy (TUMT)

Intervention: Transurethral Microwave Thermotherapy (TUMT) (Device)

Investigators

Study Sites (7)

Loading locations...

Similar Trials